97 related articles for article (PubMed ID: 15236795)
1. Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease.
Shen ZX
Med Hypotheses; 2004; 63(2):308-21. PubMed ID: 15236795
[TBL] [Abstract][Full Text] [Related]
2. Brain cholinesterases: I. The clinico-histopathological and biochemical basis of Alzheimer's disease.
Shen ZX
Med Hypotheses; 2004; 63(2):285-97. PubMed ID: 15236793
[TBL] [Abstract][Full Text] [Related]
3. Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
Shen ZX
Med Hypotheses; 2004; 63(2):298-307. PubMed ID: 15236794
[TBL] [Abstract][Full Text] [Related]
4. Rationale for diagnosing deficiency of ChEs and for applying exogenous HuChEs to the treatment of diseases.
Shen ZX
Med Hypotheses; 2008; 70(1):43-51. PubMed ID: 17587508
[TBL] [Abstract][Full Text] [Related]
5. Acid phosphatase activity in senile plaques and cerebrospinal fluid of patients with Alzheimer's disease.
Omar R; Pappolla M; Argani I; Davis K
Arch Pathol Lab Med; 1993 Feb; 117(2):166-9. PubMed ID: 8427565
[TBL] [Abstract][Full Text] [Related]
6. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
7. Expression of cholinesterases in brain and non-brain tumours.
Vidal CJ
Chem Biol Interact; 2005 Dec; 157-158():227-32. PubMed ID: 16256970
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease pathogenesis: role of aging.
Harman D
Ann N Y Acad Sci; 2006 May; 1067():454-60. PubMed ID: 16804026
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of serum or cerebrospinal fluid levels of toxic advanced glycation end-products (TAGE) in early detection of Alzheimer's disease.
Takeuchi M; Sato T; Takino J; Kobayashi Y; Furuno S; Kikuchi S; Yamagishi S
Med Hypotheses; 2007; 69(6):1358-66. PubMed ID: 17888585
[TBL] [Abstract][Full Text] [Related]
10. Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete.
MacDonald AB
Med Hypotheses; 2006; 67(3):592-600. PubMed ID: 16675154
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.
MacDonald AB
Med Hypotheses; 2007; 68(4):822-5. PubMed ID: 17055667
[TBL] [Abstract][Full Text] [Related]
12. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterases within neurofibrillary tangles related to age and Alzheimer's disease.
Mesulam MM; Asuncion Morán M
Ann Neurol; 1987 Aug; 22(2):223-8. PubMed ID: 3662453
[TBL] [Abstract][Full Text] [Related]
14. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance.
Balaraman Y; Limaye AR; Levey AI; Srinivasan S
Cell Mol Life Sci; 2006 Jun; 63(11):1226-35. PubMed ID: 16568235
[TBL] [Abstract][Full Text] [Related]
16. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
Suzuki T; Araki Y; Yamamoto T; Nakaya T
J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
[TBL] [Abstract][Full Text] [Related]
17. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
18. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
[TBL] [Abstract][Full Text] [Related]
19. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
[TBL] [Abstract][Full Text] [Related]
20. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
